oxybutynin has been researched along with Burns, Chemical in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Burns, Chemical: Burns caused by contact with or exposure to CAUSTICS or strong ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As of 2018, the FDA Adverse Event Reporting System public dashboard lists a total of 2889 reports of safety problems with the patch, 904 of which were classified as serious." | 1.48 | Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process. ( Burch, RC; Loder, EW; Rayhill, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loder, EW | 1 |
| Rayhill, M | 1 |
| Burch, RC | 1 |
1 other study available for oxybutynin and Burns, Chemical
| Article | Year |
|---|---|
Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.
Topics: Adverse Drug Reaction Reporting Systems; Burns, Chemical; Cicatrix; Clinical Trials as Topic; Drug A | 2018 |